| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Exact Sciences Corp (EXAS) has 14 insiders with recent SEC Form 4 filings, including 0 buys and 11 sells. EXAS is classified in the Life Sciences Tools & Services industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| VP | 191.9K | - | - | |
| VP | 153.7K | - | - | |
| CFO | 138.7K | - | - | |
| VP | 137.2K | - | - | |
| Dir | 13.9K | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jul 30, 2018 | Zanotti Katherine S50 | Director | Sell | 2,847 | $58.86 | $167,574.42 | -2.6% | |
| Jul 30, 2018 | Carey Thomas D. | Director | Sell | 3,427 | $58.86 | $201,713.22 | -6.5% | |
| Jul 30, 2018 | Fallon John A. | Director | Sell | 2,373 | $58.86 | $139,674.78 | -6.6% | |
| Jul 30, 2018 | Doyle James Edward75 | Director | Sell | 1,318 | $58.86 | $77,577.48 | -3.4% | |
| Jul 30, 2018 | Elliott Jeffrey Thomas79 | Chief Financial Officer | Sale+OE | 8,984 | $57.78 | $519,095.52 | -21.7% | |
| Jul 2, 2018 | Coward D Scott77 | SVP And General Counsel | Sale+OE | 2,135 | $59.10 | $126,176.36 | -2.8% | |
| May 10, 2018 | Wyzga Michael S | Director | Sell | 7,402 | $51.53 | $381,447.27 | -40.3% | |
| Apr 12, 2018 | Zanotti Katherine S50 | Director | Sell | 7,232 | $45.00 | $325,440.00 | -6.4% | |
| Apr 10, 2018 | Carey Thomas D. | Director | Sell | 8,448 | $39.73 | $335,629.70 | -7.4% | |
| Apr 10, 2018 | Doyle James Edward75 | Director | Sell | 3,098 | $40.97 | $126,925.06 | -8.1% |